Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Breast Care (Basel, Switzerland)|February 20, 2018
Neoadjuvant Chemotherapy Exerts Selection Pressure Towards Luminal Phenotype Breast CancerGiulia Galli, Giacomo Bregni, Stefano Cavalieri, et al.
Investigational New Drugs|February 14, 2016
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancerAndrea Necchi, Salvatore Lo Vullo, Luigi Mariani, et al.
International Journal of Molecular Sciences|August 28, 2025
Interobserver Agreement in Immunohistochemical Evaluation of Folate Receptor Alpha (FRα) in Ovarian Cancer: A Multicentre StudyGian Franco Zannoni, Giuseppe Angelico, Antonio d'Amati, et al.
Clinical Genitourinary Cancer|September 7, 2014
Immunohistochemistry to enhance prognostic allocation and guide decision-making of patients with advanced urothelial cancer receiving first-line chemotherapyAndrea Necchi, Patrizia Giannatempo, Biagio Paolini, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2020
Hysteroscopic versus cervical injection for sentinel node detection in endometrial cancer: A multicenter prospective randomised controlled trial from the Multicenter Italian Trials in Ovarian cancer (MITO) study groupAntonino Ditto, Ivan Casarin, Ciro Pinelli, et al.
British Journal of Cancer|April 9, 2026
Salvage post-chemotherapy retroperitoneal lymph-node dissection: evolving paradigm for marker-positive non-seminomatous germ-cell tumors managementSebastiano Nazzani, Carlo Silvani, Cesare Saitta, et al.
Minerva Urology and Nephrology|January 27, 2026
Management of monorchid patients with previous testis cancer: the role of frozen sections and the real possibility of testis sparing surgery in a large retrospective seriesSebastiano Nazzani, Ruggero Darisi, Mario Catanzaro, et al.
Thyroid : Official Journal of the American Thyroid Association|June 24, 2026
Targeted Therapy-Induced Erythrocytosis in Thyroid Cancers: An Underrecognized Safety Signal from a Retrospective StudySilvia Marchesi, Rebecca Romanò, Andrea Spagnoletti, et al.
Plos One|August 8, 2019
Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE studySerena Di Cosimo, Nicla La Verde, Anna Moretti, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2025
Clinical evaluation of the role of miRNA 371 in small testicular masses. Results of the "S1STeM 371" TrialSebastiano Nazzani, Adele Busico, Valentina Bernasconi, et al.
Pageof 9